Upgrade to SI Premium - Free Trial

SurModics (SRDX) Tops Q3 EPS by 10c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus

July 31, 2019 5:53 PM
SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.15, $0.10 better than the analyst estimate of $0.05. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Hot Guidance

Next Articles